Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

8.1%

3 terminated/withdrawn out of 37 trials

Success Rate

89.3%

+2.8% vs industry average

Late-Stage Pipeline

16%

6 trials in Phase 3/4

Results Transparency

20%

5 of 25 completed trials have results

Key Signals

2 recruiting5 with results

Enrollment Performance

Analytics

N/A

7(46.7%)

Phase 4

4(26.7%)

Phase 3

2(13.3%)

Phase 2

2(13.3%)

15Total

N/A(7)

Phase 4(4)

Phase 3(2)

Phase 2(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (37)

Showing 20 of 37 trials

NCT06289647Phase 4Withdrawn

Azithromycin Reduction to Reach Elimination of Trachoma B

Role: collaborator

NCT06579885Completed

Ocular Complications of Mpox in the Democratic Republic Congo

Role: collaborator

NCT05734508Phase 4Completed

Assessment of Safety Profile of MVA-BN Vaccine in the PALM-007 Study in DRC

Role: collaborator

NCT05096091Completed

International Study on COVID-19 Vaccine to Assess Immunogenicity, Reactogenicity and Efficacy (InVITE)

Role: collaborator

NCT05559099Phase 2Completed

Tecovirimat for Treatment of Monkeypox Virus

Role: collaborator

NCT04409405Completed

Evaluation and Support to EVD Cured Patients and Their Contacts (Les Vainqueurs d'Ebola)

Role: collaborator

NCT07093489Not Yet Recruiting

Evaluation of Effectiveness and Safety of LC16m8 Mpox Vaccine in the Democratic Republic of Congo (DRC)

Role: collaborator

NCT06721585Completed

Tecovirimat for Treatment of Monkeypox Virus - Study Extension Providing Standard of Care Only

Role: collaborator

NCT07055867Enrolling By Invitation

Epidemiological and Clinical Characteristics of Mpox Outbreak in Equateur, the DR Congo (Part1)

Role: collaborator

NCT06984705Enrolling By Invitation

Epidemiological and Clinical Characteristics of Human Mpox Outbreak in Equateur Province in the Democratic Republic of Congo (Part3)

Role: collaborator

NCT06981442Not ApplicableRecruiting

Implementation and Evaluation of Vector Control Methods in Kinshasa: The Case of Aedes

Role: collaborator

NCT06136117Completed

Monkeypox, Biology, Outcome, Transmission and Epidemiology -Prospective Follow-up of High-risk Contacts

Role: collaborator

NCT06840860Recruiting

Epidemiological and Pathophysiological Insights Through a Cross-sectional Survey (EPIC)

Role: collaborator

NCT04760678Completed

Febrile Illness in Kinshasa and Kimpese

Role: collaborator

NCT04036708Not ApplicableCompleted

Caregiver Training to Prevent Konzo Disease in Children in Democratic Republic of Congo (DRC)

Role: collaborator

NCT06356974Phase 3Not Yet Recruiting

Stop Transmission of Gambiense Human African Trypanosomiasis (STROgHAT)

Role: collaborator

NCT04012164Not ApplicableCompleted

Viral and Microbial Circulation Between Humans, Domesticated and Wild Animals Along an Ecotone, Democratic Republic of Congo

Role: collaborator

NCT05645822Withdrawn

Screen and Treat Implementation for HAT Control

Role: collaborator

NCT05119426Phase 4Unknown

Effectiveness of a Typhoid Conjugate Vaccine in DRC

Role: collaborator

NCT03303963Completed

DIAgnostics for Multidrug Resistant Tuberculosis in Africa

Role: collaborator